Princeton Alpha Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-35,766
Closed -$1.95M 61
2017
Q1
$1.95M Buy
35,766
+26,661
+293% +$1.46M 0.65% 16
2016
Q4
$532K Sell
9,105
-50,264
-85% -$2.75M 0.11% 296
2016
Q3
$3.2M Buy
59,369
+23,289
+65% +$1.5M 0.6% 14
2016
Q2
$2.65M Buy
36,080
+18,984
+111% +$1.34M 0.47% 21
2016
Q1
$1.09M Buy
+17,096
New +$1.08M 0.18% 185
2015
Q2
Sell
-45,606
Closed -$2.94M 715
2015
Q1
$2.94M Buy
+45,606
New +$2.86M 0.63% 22
2014
Q4
Sell
-14,591
Closed -$747K 678
2014
Q3
$747K Buy
14,591
+2,918
+25% +$146K 0.17% 157
2014
Q2
$566K Buy
11,673
+5,324
+84% +$262K 0.12% 269
2014
Q1
$330K Buy
+6,349
New +$338K 0.1% 319

Other funds holding BMY

Princeton Alpha Management's BMY Position: Q2 2017 in Review

Princeton Alpha Management sold out of Bristol-Myers Squibb (BMY) in Q2 2017, closing a stake of 35,766 shares — an estimated $1.95M sold.

Princeton Alpha Management first reported a position in BMY in Q1 2014 and held it in 9 quarters. The position peaked at $3.2M in Q3 2016. 1,594 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

  • Princeton Alpha Management reported no remaining Bristol-Myers Squibb position as of Q2 2017 after selling out during the quarter.
  • Princeton Alpha Management sold 35,766 Bristol-Myers Squibb shares in Q2 2017, an estimated $1.95M.
  • Princeton Alpha Management first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 9 quarters.
  • Princeton Alpha Management's Bristol-Myers Squibb position peaked at $3.2M in Q3 2016.
  • 1,594 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Princeton Alpha Management's 13F filing for Q2 2017.